Literature DB >> 32743581

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State.

Rachael A Mansbach, Srirupa Chakraborty, Kien Nguyen, David Montefiori, Bette Korber, S Gnanakaran.   

Abstract

The COVID-19 pandemic underwent a rapid transition with the emergence of a SARS-CoV-2 variant that carried the amino acid substitution D614G in the Spike protein that became globally prevalent. The G-form is both more infectious in vitro and associated with increased viral loads in infected people. To gain insight into the mechanism underlying these distinctive characteristics, we employed multiple replicas of microsecond all-atom simulations to probe the molecular-level impact of this substitution on Spike closed and open states. The open state enables Spike interactions with its human cellular receptor, ACE2. Here we show that changes in the inter-protomer energetics due to the D614G substitution favor a higher population of infection-capable (open) states. The inter-protomer interactions between S1 and S2 subunits in the open state of the D-form are asymmetric. This asymmetry is resolved in the G-form due to the release of tensile hydrogen bonds resulting in an increased population of open conformations. Thus, the increased infectivity of the G-form is likely due to a higher rate of profitable binding encounters with the host receptor. It is also predicted to be more neutralization sensitive due to enhanced exposure of the receptor binding domain, a key target region for neutralizing antibodies.

Entities:  

Year:  2020        PMID: 32743581      PMCID: PMC7386500          DOI: 10.1101/2020.07.26.219741

Source DB:  PubMed          Journal:  bioRxiv


  3 in total

Review 1.  COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.

Authors:  Suhad Daher-Nashif; Rania Al-Anany; Menatalla Ali; Khadija Erradi; Elmoubasher Farag; Abdallah M Abdallah; Mohamed M Emara
Journal:  Arch Virol       Date:  2022-06-20       Impact factor: 2.685

Review 2.  Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19.

Authors:  Junsen Chen; Rui Huang; Yiwen Nie; Xinyue Wen; Ying Wu
Journal:  Virol Sin       Date:  2021-01-04       Impact factor: 4.327

3.  Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.

Authors:  Alice Massacci; Eleonora Sperandio; Lorenzo D'Ambrosio; Mariano Maffei; Fabio Palombo; Luigi Aurisicchio; Gennaro Ciliberto; Matteo Pallocca
Journal:  J Transl Med       Date:  2020-12-30       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.